Uveitis, Anterior, Childhood

No Results

No Results

processing….

Anterior uveitis occurs in association with a variety of systemic conditions. Since the clinical features present on ophthalmic examination may not point toward a specific cause, the emphasis on general medical history and physical examination, the use of directed laboratory testing, and a referral to a pediatric rheumatologist, are appropriate. ^{[1, 2]}

In this article, anterior uveitis associated with juvenile idiopathic arthritis (JIA) and entities related to human leukocyte antigen B27 (HLA-B27) are covered, including juvenile ankylosing spondylitis (AS), reactive arthritis (also referred to as Reiter syndrome), and inflammatory bowel disease. Also included are sarcoidosis, which may present with a nongranulomatous anterior uveitis, Blau syndrome, acute tubulointerstitial nephritis and uveitis, and Kawasaki disease. Brief coverage is given to uveitis related to systemic viral infections.

The pathophysiology of these entities is diverse, and the specific entities are covered in more detail below. For example, poorly controlled uveitis related to JIA may progress to band keratopathy, hypotony, and phthisis, whereas the iritis related to Kawasaki disease is self-limited and generally benign.

Causes of anterior uveitis in children may be classified broadly as infectious and noninfectious. The common and important infectious causes are due to viruses (eg, herpes simplex, herpes zoster) and following systemic viral syndromes (eg, mumps). Uveitis associated with herpes simplex often is accompanied by keratitis, making the diagnosis straightforward. Uveitis in children with herpes zoster usually occurs in the setting of immune suppression, such as AIDS. ^{[3, 4, 5]}

Noninfectious causes of childhood anterior uveitis are more common; the strongest association is with JIA. In JIA, the patient may be asymptomatic as the process quietly proceeds to band keratopathy, cataract, and glaucoma. Spondyloarthropathies (eg, AS, psoriatic arthritis, reactive arthritis, inflammatory bowel disease) also are associated strongly with nongranulomatous anterior uveitis. Sarcoidosis is an important cause of panuveitis but may present as an isolated nongranulomatous anterior uveitis.

United States

Approximately 6% of all cases of uveitis occur in children, with most cases occurring in association with JIA and the spondyloarthropathies. Uveitis can occur in 4 of the 7 categories of JIA, including oligoarthritis, rheumatoid factor (RF)-negative polyarthritis, enthesitis-related arthritis, and psoriatic arthritis.

Oligoarthritis affects 4 or fewer joints and typically occurs in young girls. Oligoarthritis is the most common type of JIA in Europe and North America. Uveitis most often accompanies this form of the disease and is seen in about 10-30% of patients. Antinuclear antibodies are common in this group of children. Uveitis occurs in up to 10% of children with RF-negative polyarthritis JIA. Enthesitis-related arthritis affects the attachments of ligaments and tendons to the bone. This form of JIA typically affects older boys. Uveitis is often unilateral with a sudden onset; children are often symptomatic. Approximately 10% of children with psoriatic arthritis develop uveitis. In these children, the uveitis is usually chronic and asymptomatic.

Of patients with AS, 20-30% develop uveitis; of patients with reactive arthritis, 12-37% develop uveitis; and, of patients with inflammatory bowel disease, 2-9% develop uveitis.

Uveitis associated with sarcoidosis is significantly less common in children compared to JIA-related causes and uveitis related to spondyloarthropathy. In one large series of childhood uveitis, it accounted for less than 1% of cases.

International

Uveitis in children and adolescents is less common than in adults. However, the reported percentage of children affected varies widely, ranging from 2.2-33.1% of all patients with uveitis. In a large study from Israel, anterior uveitis accounted for 13.4% of all cases of uveitis affecting children and adolescents.

Morbidity in childhood anterior uveitis may result from lack of treatment or from overzealous treatment.

The primary causes of ocular and visual morbidity in pediatric anterior uveitis are similar among the various entities, with the primary differences related to severity, chronicity, treatment success, complications, and age of onset.

Acute episodes of inflammation may be self-limited and benign or may cause anterior and posterior synechiae, with secondary glaucoma. Chronic anterior uveitis additionally may cause band keratopathy, cataract, spillover anterior vitreitis, and cystoid macular edema. Severe glaucoma and phthisis are the most feared complications.

Sarcoidosis affects African Americans about 10 times more often than it affects whites. However, most young children with uveitis are white.

AS is 2-3 times more common in boys than in girls.

Reactive arthritis is at least 5 times more common in boys than in girls.

Sarcoidosis is slightly more common in girls than in boys.

Oligoarthritis JIA is more common in females than in boys, with a girl-to-boy ratio of 3-4:1.

Most children with oligoarthritis JIA are younger than 4 years, while children with RF-negative polyarthritis JIA are somewhat older. Enthesitis-related arthritis typically affects older boys. ^{[6, 7]}

Mean age of onset of AS is about 10 years and 10-11 years in psoriatic arthritis.

Children (and parents/guardians) with childhood anterior uveitis require prolonged education regarding the signs and symptoms of disease activity. It is important to stress the need for lifestyle changes to decrease and prevent exacerbations and to preserve current remaining vision and the need for appropriate pain management. Children complain less regarding visual symptoms and require regular eye visits to check for signs of ocular inflammation.

Holland GN, Denove CS, Yu F. Chronic anterior uveitis in children: clinical characteristics and complications. Am J Ophthalmol. 2009 Apr. 147(4):667-678.e5. [Medline].

Hooper C, McCluskey P. Intraocular inflammation: its causes and investigations. Curr Allergy Asthma Rep. 2008 Jul. 8(4):331-8. [Medline].

Zaborowski AG, Parbhoo D, Chinniah K, Visser L. Uveitis in children with human immunodeficiency virus-associated arthritis. J AAPOS. 2008 Dec. 12(6):608-10. [Medline].

Spratt A, Key T, Vivian AJ. Chronic anterior uveitis following bacille Calmette-Guérin vaccination: molecular mimicry in action?. J Pediatr Ophthalmol Strabismus. 2008 Jul-Aug. 45(4):252-3. [Medline].

Rothova A, Schneider M, de Groot-Mijnes JD. Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. Ophthalmology. 2008 Nov. 115(11):2062-4. [Medline].

BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005 Apr. 89(4):444-8. [Medline].

Zierhut M, Michels H, Stubiger N, Besch D, Deuter C, Heiligenhaus A. Uveitis in children. Int Ophthalmol Clin. 2005. 45(2):135-56. [Medline].

Monheit BE, Read RW. Optic disk edema associated with sudden-onset anterior uveitis. Am J Ophthalmol. 2005 Oct. 140(4):733-5. [Medline].

Ayuso VK, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010 Jun. 149(6):987-93. [Medline].

Wensing B, Relvas LM, Caspers LE, Valentincic NV, Stunf S, de Groot-Mijnes JD. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Ophthalmology. 2011 Oct. 118(10):1905-10. [Medline].

Levinson RD. Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin. 2008 Summer. 48(3):51-9. [Medline].

Ur Rehman S, Anand S, Reddy A, Backhouse OC, Mohamed M, Mahomed I. Poststreptococcal syndrome uveitis: a descriptive case series and literature review. Ophthalmology. 2006 Apr. 113(4):701-6. [Medline].

Atmaca L, Boyvat A, Yalçindag FN, Atmaca-Sonmez P, Gurler A. Behçet disease in children. Ocul Immunol Inflamm. 2011 Apr. 19(2):103-7. [Medline].

Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010 Jul. 117(7):1436-41. [Medline].

Gregory AC 2nd, Kempen JH, Daniel E, Kacmaz RO, Foster CS, Jabs DA. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013 Jan. 120(1):186-92. [Medline].

Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. 2011 Feb. 151(2):217-22. [Medline].

Goebel JC, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol. 2011 Feb. 95(2):209-13. [Medline].

Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond). 2011 Apr. 25(4):427-35. [Medline]. [Full Text].

Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). 2006 Aug. 45(8):982-9. [Medline].

Gallagher M, Quinones K, Cervantes-Castañeda RA, Yilmaz T, Foster CS. Biological response modifier therapy for refractory childhood uveitis. Br J Ophthalmol. 2007 Oct. 91(10):1341-4. [Medline].

Zierhut M, Doycheva D, Biester S, Stübiger N, Kümmerle-Deschner J, Deuter C. Therapy of uveitis in children. Int Ophthalmol Clin. 2008 Summer. 48(3):131-52. [Medline].

Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007 Mar. 91(3):319-24. [Medline].

Magli A, Forte R, Navarro P, Russo G, Orlando F, Latanza L. Adalimumab for juvenile idiopathic arthritis-associated uveitis. Graefes Arch Clin Exp Ophthalmol. 2013 Jun. 251(6):1601-6. [Medline].

Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol. 2013 Jan. 40(1):74-9. [Medline].

Nemet AY, Raz J, Sachs D, Friling R, Neuman R, Kramer M. Primary intraocular lens implantation in pediatric uveitis: a comparison of 2 populations. Arch Ophthalmol. 2007 Mar. 125(3):354-60. [Medline].

Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology. 2006 Feb. 113(2):308-14. [Medline].

Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). 2006 Aug. 45(8):982-9. [Medline].

Banares A, Hernandez-Garcia C, Fernandez-Gutierrez B, Jover JA. Eye involvement in the spondyloarthropathies. Rheum Dis Clin North Am. 1998 Nov. 24(4):771-84, ix. [Medline].

de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003 Jul. 87(7):879-84. [Medline].

Edmunds L, Elswood J, Calin A. New light on uveitis in ankylosing spondylitis. J Rheumatol. 1991 Jan. 18(1):50-2. [Medline].

Flynn HW Jr, Davis JL, Culbertson WW. Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis. Ophthalmology. 1988 Aug. 95(8):1114-9. [Medline].

Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2003 Dec. 14(6):395-8. [Medline].

Fox GM, Flynn HW Jr, Davis JL, Culbertson W. Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis. Am J Ophthalmol. 1992 Dec 15. 114(6):708-14. [Medline].

Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford). 2011 Aug. 50(8):1390-4. [Medline].

Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin. 1992. 32(1):241-52. [Medline].

Hofley P, Roarty J, McGinnity G, Griffiths AM, Marcon M, Kraft S, et al. Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 1993 Nov. 17(4):397-400. [Medline].

Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984 Oct. 91(10):1247-52. [Medline].

Leirisalo-Repo M. Enteropathic arthritis, Whipple’s disease, juvenile spondyloarthropathy, and uveitis. Curr Opin Rheumatol. 1994 Jul. 6(4):385-90. [Medline].

Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol. 2003 Jun. 135(6):879-84. [Medline].

Rennebohm RM, Burke MJ, Crowe W, Levinson JE. Anterior uveitis in Kawasaki’s disease. Am J Ophthalmol. 1981 Apr. 91(4):535-7. [Medline].

Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uveitis. Ophthalmology. 2004 Dec. 111(12):2299-306. [Medline].

Shore A, Ansell BM. Juvenile psoriatic arthritis–an analysis of 60 cases. J Pediatr. 1982 Apr. 100(4):529-35. [Medline].

Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996 Jan. 121(1):47-56. [Medline].

Weinreb RN, Tessler H. Laboratory diagnosis of ophthalmic sarcoidosis. Surv Ophthalmol. 1984 May-Jun. 28(6):653-64. [Medline].

Wolf MD, Lichter PR, Ragsdale CG. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987 Oct. 94(10):1242-8. [Medline].

Manolette R Roque, MD, MBA, FPAO Section Chief, Ocular Immunology and Uveitis, Department of Ophthalmology, Asian Hospital and Medical Center; Section Chief, Ocular Immunology and Uveitis, International Eye Institute, St Luke’s Medical Center Global City; Senior Eye Surgeon, The LASIK Surgery Clinic; Director, AMC Eye Center, Alabang Medical Center

Manolette R Roque, MD, MBA, FPAO is a member of the following medical societies: American Academy of Ophthalmic Executives, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, American Society of Ophthalmic Administrators, American Uveitis Society, International Ocular Inflammation Society, Philippine Medical Association, Philippine Ocular Inflammation Society, Philippine Society of Cataract and Refractive Surgery

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Steve Charles, MD Founder and CEO of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine

Disclosure: Received royalty and consulting fees for: Alcon Laboratories.

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Gerhard W Cibis, MD Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas School of Medicine

Gerhard W Cibis, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Ophthalmological Society

Disclosure: Nothing to disclose.

R Christopher Walton, MD Professor, Director of Uveitis and Ocular Inflammatory Disease Service, Department of Ophthalmology, University of Tennessee College of Medicine

R Christopher Walton, MD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, Retina Society, American College of Healthcare Executives, American Uveitis Society

Disclosure: Nothing to disclose.

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthor, Peter H Spiegel, MD, to the development and writing of this article.

Uveitis, Anterior, Childhood

Research & References of Uveitis, Anterior, Childhood|A&C Accounting And Tax Services
Source

Share on Facebook

Tweet

Follow us